Ziphius Vaccines N.V.

https://www.zyphius.org

LinkedIn: https://www.linkedin.com/company/ziphius-vaccines

Ziphius Vaccines NV is a self-amplifying RNA company developing transformative vaccines for infectious diseases and protein replacement, in order to create a new generation of medicines. The Company has a portfolio of next generation vaccine candidates targeting a wide range of infectious diseases. Headquartered in Ghent, Belgium, Ziphius Vaccines currently has strategic partnerships with experienced executives in the pharmaceutical industry that bring over 100 years of combined expertise in drug development. *

	Start	2019-01-01 established
	Industry	mRNA-based vaccine
	Industry 2	RNA technology
	Person	Cardon, Chris (Ziphius Vaccine 202105 CEO + Founder)
	Person 2	Ghadanfar, Mathieu (Ziphius Vaacines 202106 Business Development Officer + CMO)

	Region	Gent (Ghent)
	Country	Belgium
	Street	19 Heidestraat
	City	9820 Merelbeke
		Address record changed: 2021-06-07

Basic data	Employees	B: 11 to 50 (2021-06-02)

		* Document for »About Section«: Ziphius Vaccines N.V.. (5/25/21). "Press Release: Ziphius Vaccines Raises €29.3M in Oversubscribed Series A Financing".

		Record changed: 2024-02-12